550 related articles for article (PubMed ID: 27920024)
1. Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.
Guo L; Shorter J
Cold Spring Harb Perspect Med; 2017 Sep; 7(9):. PubMed ID: 27920024
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding proteins with prion-like domains in health and disease.
Harrison AF; Shorter J
Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
[TBL] [Abstract][Full Text] [Related]
3. Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assembly.
Shorter J; Taylor JP
Rare Dis; 2013; 1():e25200. PubMed ID: 25002999
[TBL] [Abstract][Full Text] [Related]
4. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease.
March ZM; King OD; Shorter J
Brain Res; 2016 Sep; 1647():9-18. PubMed ID: 26996412
[TBL] [Abstract][Full Text] [Related]
5. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.
Guo L; Kim HJ; Wang H; Monaghan J; Freyermuth F; Sung JC; O'Donovan K; Fare CM; Diaz Z; Singh N; Zhang ZC; Coughlin M; Sweeny EA; DeSantis ME; Jackrel ME; Rodell CB; Burdick JA; King OD; Gitler AD; Lagier-Tourenne C; Pandey UB; Chook YM; Taylor JP; Shorter J
Cell; 2018 Apr; 173(3):677-692.e20. PubMed ID: 29677512
[TBL] [Abstract][Full Text] [Related]
6. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
Ratti A; Buratti E
J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
[TBL] [Abstract][Full Text] [Related]
7. Engineering enhanced protein disaggregases for neurodegenerative disease.
Jackrel ME; Shorter J
Prion; 2015; 9(2):90-109. PubMed ID: 25738979
[TBL] [Abstract][Full Text] [Related]
8. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
9. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy.
Chen HJ; Topp SD; Hui HS; Zacco E; Katarya M; McLoughlin C; King A; Smith BN; Troakes C; Pastore A; Shaw CE
Brain; 2019 Dec; 142(12):3753-3770. PubMed ID: 31605140
[TBL] [Abstract][Full Text] [Related]
10. [TDP-43 proteinopathies - from frontotemporal lobar degeneration to inclusion body myositis].
Kierdaszuk B; Berdyński M; Zekanowski C; Kamińska A
Neurol Neurochir Pol; 2012; 46(4):384-91. PubMed ID: 23023438
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of TDP-43 Proteinopathy Onset and Propagation.
Chen HJ; Mitchell JC
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199367
[TBL] [Abstract][Full Text] [Related]
12. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases.
Warraich ST; Yang S; Nicholson GA; Blair IP
Int J Biochem Cell Biol; 2010 Oct; 42(10):1606-9. PubMed ID: 20601083
[TBL] [Abstract][Full Text] [Related]
13. Nuclear-Import Receptors Counter Deleterious Phase Transitions in Neurodegenerative Disease.
Odeh HM; Fare CM; Shorter J
J Mol Biol; 2022 Jan; 434(1):167220. PubMed ID: 34464655
[TBL] [Abstract][Full Text] [Related]
14. De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies.
Mitsuhashi K; Ito D; Mashima K; Oyama M; Takahashi S; Suzuki N
Sci Rep; 2017 Dec; 7(1):16871. PubMed ID: 29203801
[TBL] [Abstract][Full Text] [Related]
15. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
Kim HJ; Kim NC; Wang YD; Scarborough EA; Moore J; Diaz Z; MacLea KS; Freibaum B; Li S; Molliex A; Kanagaraj AP; Carter R; Boylan KB; Wojtas AM; Rademakers R; Pinkus JL; Greenberg SA; Trojanowski JQ; Traynor BJ; Smith BN; Topp S; Gkazi AS; Miller J; Shaw CE; Kottlors M; Kirschner J; Pestronk A; Li YR; Ford AF; Gitler AD; Benatar M; King OD; Kimonis VE; Ross ED; Weihl CC; Shorter J; Taylor JP
Nature; 2013 Mar; 495(7442):467-73. PubMed ID: 23455423
[TBL] [Abstract][Full Text] [Related]
16. TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43.
Gendron TF; Rademakers R; Petrucelli L
J Alzheimers Dis; 2013; 33 Suppl 1(Suppl 1):S35-45. PubMed ID: 22751173
[TBL] [Abstract][Full Text] [Related]
17. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
18. Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils.
Dhakal S; Wyant CE; George HE; Morgan SE; Rangachari V
J Mol Biol; 2021 May; 433(10):166953. PubMed ID: 33771571
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain.
Wang G; Yang H; Yan S; Wang CE; Liu X; Zhao B; Ouyang Z; Yin P; Liu Z; Zhao Y; Liu T; Fan N; Guo L; Li S; Li XJ; Lai L
Mol Neurodegener; 2015 Sep; 10():42. PubMed ID: 26334913
[TBL] [Abstract][Full Text] [Related]
20. Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains.
Yin P; Guo X; Yang W; Yan S; Yang S; Zhao T; Sun Q; Liu Y; Li S; Li XJ
Acta Neuropathol; 2019 Jun; 137(6):919-937. PubMed ID: 30810811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]